Journals / Retina-Vitreus / 2018 / Cilt: 27 - Sayı: 1

Treatment of Subhyaloid Hemorrhages in Valsalva Retinopathy After Cataract Surgery

Katarakt Cerrahisi Sonrası Valsalva Retinopatisine Bağlı Gelişen Subhyaloid Kanama ve Tedavisi

Pages
90–93
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

There was signifi cant reduction of premacular haemorrhage and her vision improved to 7/10 after injection on the fi nal visit.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:VR is a rare condition that causes a sudden vision loss.
📊
Key Findings & Data:Ourcase was a 64 years old woman was presented with preretinal haemorrhage including macular area in right eye secondary to VR afteran uneventful cataract surgery under general anesthesia.
💡
Conclusion & Impact:There was signifi cant reduction of premacular haemorrhage and her vision improved to 7/10 after injection on the fi nal visit.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

VR is a rare condition that causes a sudden vision loss. Although VR is considered to be rare but a serious complication of surgery. Ourcase was a 64 years old woman was presented with preretinal haemorrhage including macular area in right eye secondary to VR afteran uneventful cataract surgery under general anesthesia. Her vision was counting fi ngers after the surgery. Although surgical correctionor Nd:YAG laser hyaloidotomy was available she was treated with single intravitreal TPA, intravitreal bevacizumab and 0.2cc SF6 gaseinjection. There was signifi cant reduction of premacular haemorrhage and her vision improved to 7/10 after injection on the fi nal visit.

Özet

Valsalva retinopatisi (VR) ani görme kaybına neden olabilen nadir bir durumdur. VR nadir görülmekle birlikte önemli bir cerrahi komplikasyondur. 64 yaşında bayan hastada komplikasyonsuz katarakt cerrahisi sonrası VR’ne bağlı makuler alanı içine alan preretinal kanama saptanmıştır. Cerrahi sonrası hastanın görme seviyesi el hareketi düzeyindedir. Cerrahi tedavi veya Nd:YAG lazer hyaloidotomi mümkün olsa da hastamız intravitreal TPA, intravitreal bevacizumab ve 0.2cc SF6 gaz injeksiyonu ile tedavi edilmiştir.Son muayenede premakuler kanamada gerileme saptanmış ve hastanın görmesi 7/10 düzeyine yükselmiştir.

🔖

Cite This Article

DEMİR, S. T., OLGUN, A., TÜRKER, İ. Ç., DİRİM, A. B., ŞENDÜL, Y., GÜVEN, D. (2022). Treatment of Subhyaloid Hemorrhages in Valsalva Retinopathy After Cataract Surgery. Retina-Vitreus, Cilt: 27 - Sayı: 1, 90–93. https://ajindex.com/articles/589127

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (2)

  1. Mennel S. Subhyaloidal and macular haemorrhage: localisa- tion and treatment strategies. British Journal of Ophthalmology. 2007;91(7):850–852. Russell S. Hemorrhagic detachment of the internal limiting mem- brane after penetrating ocular injury. Retina. 1992;12(4):346–350. Iijima H. Nd:YAG laser photodisruption for preretinal hemor- rhage due to retinal macroaneurysm. Retina. 1998;18(5):430–434. Meier P. Vitrectomy for premacular hemorrhagic cyst in children and young adults. Graefe’s Archive for Clinical and Experimental Ophthalmology. 2005;243(8):824–828. Divyalakshmi K. Ocular manifestations of aplastic anaemia fol- lowing platelet transfusion. Nitte University Journal of Health Sci- ence. 2014;4(4):104–106. Duane T.D. Valsalva hemorrhagic retinopathy. Trans Am Ophthal- mol Soc. 1972;70:298–313. Sakamoto S.-I. Double ring sign at the macula in a patient with Valsalva retinopathy. QJM. 2014;107:1045–1046.
  2. Morris R. Witherspoon C.D., Mester V., Dooner J. Hemorrhagic macular cysts in Terson’s syndrome and its implications for macu- lar surgery. Dev Ophthalmol. 1997;29:44–54. Bourne RA. Treatment of preretinal Valsalva hemorrhages with neodymium: YAG laser. Eye. 1999;13:791–793. Kaynak S. Nd:YAG laser posterior hyaloidotomy in subhyaloid hemorrhage. Ophthalmic Surg 1994, 25:474-476. Celebi S. Photodisruptive Nd:YAG laser in the management of premacular subhyaloid hemorrhage. Eur J Ophthalmol 2001;11:281-286. Özcan AA. Subhyaloid Hemoraji: Tedavi ve Prognoz. T Oft Gaz. 2006;36:430-434. Ramsay RC. Timing of vitrectomy for active proliferative diabetic retinopathy. Ophthalmology. 1986; 93:283-289. Özeryürk Y. Subhyaloid kanamada argon lazer posterior hyaloi- dotomi. Ret-Vit 2002;10:227-231. Hua R. Combine intravitreal bevacizumab with Nd: YAG laser hyaloidotomy for valsalva pre-macular haemorrhage and observe the internal limiting membrane changes: aspectralis study. Int J Ophthalmol.2013; 6: 242-245